Unknown PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT03390777

Plasma Rich in Growth Factors for Treatment of Medication Related Osteonecrosis of the Jaw

Plasma Rich in Growth Factors for Treatment of Medication Related Osteonecrosis of the Jaw: a Multicenter, Randomized, Clinical Trial

Sponsor: NYU College of Dentistry

Conditions Osteonecrosis Due to Drugs, Jaw

Interventions PRGF after surgery surgery

Updated 6 times since 2018 Last updated: Jan 4, 2018 Started: Sep 30, 2018 Primary completion: Sep 30, 2021 Completion: Jan 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Osteonecrosis Due to Drugs, Jaw and is currently ongoing. NYU College of Dentistry leads this study, which shows 6 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2/PHASE3

Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Mar 2022 — Jul 2024 [monthly]

Unknown Status PHASE2_PHASE3

Status: Not Yet Recruiting → Unknown Status
Jan 2021 — Mar 2022 [monthly]

Not Yet Recruiting PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Not Yet Recruiting PHASE2_PHASE3

▶ Show 1 earlier version

Jan 2018 — Jun 2018 [monthly]

Not Yet Recruiting PHASE2_PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

NYU College of Dentistry
Universidade da Coruña
University of Roma La Sapienza

Data source: University of Roma La Sapienza

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.